Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cost a concern as China commits to inactivated polio vaccines

This article was originally published in Scrip

Executive Summary

In an effort to respond to the World Health Organization's call for a polio-free world, China has decided to shift to the use of safer injected, inactivated polio vaccines (IPVs) by 2018, marking a step away from the current oral polio vaccine (OPV), which has been widely administered in the country since the 1960's due to its low cost and high efficacy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC023466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel